Scott Gottlieb, M.D., a practicing physician, has served in various capacities at the Food and Drug Administration, including senior adviser for medical technology; director of medical policy development; and, most recently, deputy commissioner for medical and scientific affairs. Dr. Gottlieb has also served as a senior policy adviser at the Centers for Medicare & Medicaid Services.
Click here to read Scott’s Medical Innovation blog.
Have world leaders abandoned hope of stemming the continued spread of Ebola in Western Africa? Is there current strategy to let the virus burn itself out in that region, while they focus more of their efforts on containing the virus to that region?
There's growing frustration among entrepreneurs in Silicon Valley who are finding that the road to improving medical technology ends not in Palo Alto but in White Oak, Md.—at the headquarters of the Food and Drug Administration.
Patient-Centered Outcomes Research Institute (PCORI) never had the resources to fund clinical trials that would create change, and it never had the resources to make grants sizeable enough to perform these trials. PCORI is left with two options, it can either do research on the cheap, or avoid tough medical questions. PCORI has chosen to do both.